Your Complete Monthly Budget Guide For The Switch
Why Monthly Cost Matters When Switching From Mounjaro To Wegovy
When switching from Mounjaro to Wegovy, the monthly cost structure differs significantly due to Wegovy's specific dose escalation protocol. Unlike Mounjaro's tirzepatide dual-action mechanism, Wegovy uses semaglutide as a GLP-1 receptor agonist exclusively. This means your monthly investment follows a predictable 16-week escalation schedule before reaching maintenance dosing. Understanding these costs upfront allows for better financial planning and ensures continuity of treatment without unexpected budget pressures.
The transition from Mounjaro to Wegovy involves restarting at the lowest dose, regardless of your previous Mounjaro strength. This prescription-only medicine requires careful titration to minimise side effects and optimise tolerance. Your monthly costs will therefore begin at £79.99 for the 0.25mg starter dose, progressing through each escalation phase. This structured approach to switching from Mounjaro to Wegovy ensures your body adapts properly to the new medication while maintaining cost transparency throughout.
Complete Wegovy Monthly Cost Breakdown UK
The monthly cost progression when switching from Mounjaro to Wegovy follows MHRA-approved dosing guidelines. Months 1-4 require the 0.25mg dose at £79.99 monthly with FIRST40 for new customers. Months 5-8 progress to 0.5mg at £94.99, while months 9-12 use 1mg at £99.99 monthly. The penultimate escalation covers months 13-16 with 1.7mg at £139.99, before reaching the 2.4mg maintenance dose at £209.99 monthly from month 17 onwards.
For returning customers switching from Mounjaro to Wegovy, the DOSE25 discount code applies at checkout to maintain competitive pricing throughout your journey. Bundle options can provide additional convenience, such as our Intro Duo covering your first two doses for £169.99, or the Ultimate Stability Trio providing three months of maintenance supply at 2.4mg for £649.99. These bundles ensure treatment continuity with fewer orders and assured cold-chain delivery from our GPhC-registered pharmacy.
Clinical Evidence Supporting The Switch From Mounjaro To Wegovy
The STEP clinical trial programme demonstrates Wegovy's efficacy as a prescription-only medicine for weight management. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 2 trial showed sustained results in patients with type 2 diabetes, while STEP 5 confirmed long-term efficacy at two years.
When switching from Mounjaro to Wegovy, these clinical outcomes provide confidence in the treatment decision alongside cost considerations. The recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, adding clinical value beyond weight management. However, individual results may vary, and the decision to switch should involve discussion with your prescriber about both clinical suitability and monthly cost implications.
How Wegovy Works After Switching From Mounjaro
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones in your body. Unlike Mounjaro's dual GIP and GLP-1 action, Wegovy focuses specifically on GLP-1 pathways to reduce appetite and promote satiety after smaller meals. The medication works on brain appetite centres, potentially reducing food cravings and helping you feel satisfied with reduced calorie intake. This mechanism supports weight management when combined with a reduced-calorie diet and increased physical activity. The once-weekly FlexTouch pen injection delivers consistent medication levels, maintaining appetite control throughout each week of treatment.
Streamlined Ordering Process For Your Wegovy Switch
Switching from Mounjaro to Wegovy through EverydayMeds begins with a comprehensive 3-minute online clinical assessment covering your medical history and current treatment. Our qualified prescribers review your application within 3 working days (or 24 hours with express service), ensuring clinical appropriateness for the switch. Once approved, your Wegovy prescription ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. The convenient FlexTouch pen arrives ready to use with clear dosing instructions. Our GPhC-registered pharmacy (#9012878) ensures all regulatory requirements are met throughout the switching process.
Practical Storage Considerations When Switching From Mounjaro To Wegovy
Wegovy storage requirements offer advantages over Mounjaro, particularly for travel and lifestyle flexibility. The FlexTouch pen must be stored in the fridge at 2-8°C before first use but can remain at room temperature below 30°C for up to 6 weeks once removed, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more convenient for business travel or holidays. Each pen contains four doses of the same strength, supporting the mandatory dose escalation protocol when switching from Mounjaro to Wegovy. Proper storage ensures medication potency and treatment effectiveness throughout your monthly supply.
Long-Term Financial Planning For Wegovy Maintenance Costs
After completing the 16-week escalation when switching from Mounjaro to Wegovy, your ongoing monthly investment stabilises at £209.99 for the 2.4mg maintenance dose. This translates to approximately £2,520 annually, making long-term budgeting straightforward and predictable. The DOSE25 discount code for returning customers ensures consistent pricing without unexpected increases, while our bundle options can provide supply security for 2-3 months at a time.
Comparing annual costs helps contextualise the investment in your health journey when switching from Mounjaro to Wegovy. The maintenance phase represents the most significant monthly expense but also delivers the clinical benefits demonstrated in long-term studies. Planning for this prescription-only medicine as a sustained commitment rather than short-term treatment ensures realistic expectations and successful weight management outcomes alongside lifestyle modifications.
Complete Your Switch With Confidence Through EverydayMeds
Ready to begin switching from Mounjaro to Wegovy with clear cost transparency? Visit https://everydaymeds.co.uk/collections/wegovy to start your clinical assessment and secure your starter dose at £79.99 with FIRST40 for new customers. Our qualified prescribers will guide your transition safely while our bundle options ensure treatment continuity throughout the escalation phase. Remember to use DOSE25 for future orders to maintain competitive pricing as a returning customer. The combination of clinical expertise, transparent pricing, and reliable supply makes EverydayMeds your trusted partner for this important treatment switch, supported by our GPhC registration (#9012878) and commitment to pharmaceutical excellence.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
